[Gene therapy methods for rare ophthalmological diseases in the light of distributional justice-An overview]
{{output}}
Background: Gene therapies offer promising approaches for the treatment of genetic diseases. With the approval of Neparvovec (Luxturna®, Novartis) in 2018, a gene therapy for the treatment of retinitis pigmentosa and Leber's co... ...
